Skip to main content

Advertisement

SpringerLink
Log in

The effect of short-term vitamin E against radioiodine-induced early lacrimal gland damage

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Radioiodine (RAI) is a well-known radionuclide which is used in vivo both for diagnostic and therapeutic purposes, particularly for the treatment of hyperthyroidism and thyroid cancer. Vitamin E is a well-known antioxidant vitamin. The aim of this study was to evaluate whether there was a protective effect of short-term vitamin E on RAI-induced lacrimal gland early damage in experimental animal models.

Methods

Twentyfour rats were randomly divided into two groups. The first group (RAI group) was administreted 3 mCi 131I by gastric gavage and 1 mL physiological saline intraperitoneally. The second group (RAI + Vitamin E) was administrated 3 mCi 131I by gastric gavage and 1 mL vitamin E intraperitoneally. After 24 h of the last dose being administered on the 7th day, the animals were decapitated. The lacrimal glands [Intraorbital (IG), extraorbital (EG) and harderian glands (HG)] of the rats were removed for histopathological examination.

Results

Periductal and/or periacinar fibrosis in all lacrimal glands were observed to be statistically significantly less frequent in the RAI + Vitamin E group compared to the RAI group. The existence of the abnormal lobular pattern and peripheral basophilia and irregular nucleus shape in IG and in EG, the poorly defined acidophilic cell outline and periductal infiltration in IG and in HG were observed to be statistically significantly less frequent in the RAI + Vitamin E group than in the RAI group.

Conclusion

According to study results, histopathological examinations revealed that vitamin E protects rat lacrimal glands against RAI-related early damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lee SL. Radioactive iodine therapy. Curr Opin Endocrinol Diabetes Obes. 2012;19:420–8.

    Article  CAS  PubMed  Google Scholar 

  2. Lin WY, Shen YY, Wang SJ. Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med. 1996;21:780–2.

    Article  CAS  PubMed  Google Scholar 

  3. Markitziu A, Lustmann J, Uzieli B, Krausz Y, Chisin R. Salivary and lacrimal gland involvement in a patient who had undergone a thyroidectomy and was treated with radioiodine for thyroid cancer. Oral Surg Oral Med Oral Pathol. 1993;75:318–22.

    Article  CAS  PubMed  Google Scholar 

  4. Zettinig G, Hanselmayer G, Fueger BJ, Hofmann A, Pirich C, Nepp J, et al. Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging. 2002;29:1428–32.

    Article  CAS  PubMed  Google Scholar 

  5. Silberstein EB. Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine. J Nucl Med. 2008;49(4):546–9.

    Article  PubMed  Google Scholar 

  6. Cavalieri RR. Iodine metabolism and thyroid physiology: current concepts. Thyroid. 1997;7:177–81.

    Article  CAS  PubMed  Google Scholar 

  7. Bohuslaviziki KH, Brenner W, Lassmann S, Tinnemeyer S, Tönshoff G, Sippel C, et al. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun. 1996;17:681–6.

    Article  Google Scholar 

  8. Solans R, Bosch JA, Galofré P, Porta F, Roselló J, Selva-O’Callagan A, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42(5):738–43.

    CAS  PubMed  Google Scholar 

  9. Bakheet SM, Hammami MM, Hemidan A, Powe JE, Bajaafar F. Radioiodine secretion in tears. J Nucl Med. 1998;39:1452–4.

    CAS  PubMed  Google Scholar 

  10. Zetting G, Karanikas G, Hanselmayer G, Havlik E, Dudczak R. Radioactive contamination of contact lenses during radioiodine therapy. Nucl Med Commun. 2000;21:955–7.

    Article  Google Scholar 

  11. Capizzi RL, Oster W. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol. 2000;72(4):425–35.

    CAS  PubMed  Google Scholar 

  12. Bohuslavizki KH, Klutmann S, Jenicke L, Brenner W, Feyerabend B, Henze E, et al. Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model. Int J Radiat Oncol Biol Phys. 1999;45(1):181–6.

    Article  CAS  PubMed  Google Scholar 

  13. Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J, et al. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. J Nucl Med. 2010;51(4):618–23.

    Article  CAS  PubMed  Google Scholar 

  14. Bhartiya US, Raut YS, Joseph LJ, Hawaldar RW, Rao BS. Evaluation of the radioprotective effect of turmeric extract and vitamin E in mice exposed to therapeutic dose of radioiodine. Indian J Clin Biochem. 2008;23(4):382–6.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Koca G, Yalniz-Akkaya Z, Gultekin SS, Yumusak N, Demirel K, Korkmaz M, et al. Radioprotective effect of montelukast sodium in rat lacrimal glands after radioiodine treatment. Rev Esp Med Nucl Imagen Mol. (2013) [Epub ahead of print].

  16. Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab. 1999;84:4178–84.

    Article  CAS  PubMed  Google Scholar 

  17. Nagler RM. Effects of head and neck radiotherapy on major salivary glands-animal studies and human implications. In Vivo. 2003;17:369–75.

    CAS  PubMed  Google Scholar 

  18. Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys. 2005;62:1187–94.

    Article  CAS  PubMed  Google Scholar 

  19. Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol. 1984;68:674–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Rios JD, Horikawa Y, Chen LL, Kublin CL, Hodges RR, Dartt DA, et al. Age-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory response. Exp Eye Res. 2005;80:477–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Bianchi G, Solaroli E, Zaccheroni V, Grossi G, Bargossi AM, Melchionda N, et al. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res. 1999;31:620–4.

    Article  CAS  PubMed  Google Scholar 

  22. Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, et al. Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35. Ophthalmology. 2013. Aug;120(8):1604-11.

  23. Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid. 2003;13:265–71.

    Article  CAS  PubMed  Google Scholar 

  24. Ma C, Xie J, Jiang Z, Wang G, Zuo S. Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2010;37(9):1778–85.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors haven’t used any sources of public or private financial support.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Kastamonu Faculty of Medicine, Hacettepe University, Kazakistan Caddesi 90/7 Emek, 06500, Ankara, Turkey

    Ugur Acar

  2. Department of Nuclear Medicine, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras, Turkey

    Hasan Ikbal Atilgan

  3. Department of Ophthalmology, Ministry of Health, Dr Zekai Tahir Burak Women’s Health Research and Education Hospital, Ankara, Turkey

    Damla Erginturk Acar

  4. Department of Ophthalmology, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey

    Zuleyha Yalniz-Akkaya

  5. Department of Pathology, Faculty of Veterinary Medicine, Harran University, Sanliurfa, Turkey

    Nihat Yumusak

  6. Department of Nuclear Medicine, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey

    Meliha Korkmaz & Gökhan Koca

Authors
  1. Ugur Acar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hasan Ikbal Atilgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Damla Erginturk Acar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zuleyha Yalniz-Akkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nihat Yumusak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Meliha Korkmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gökhan Koca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ugur Acar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Acar, U., Atilgan, H.I., Acar, D.E. et al. The effect of short-term vitamin E against radioiodine-induced early lacrimal gland damage. Ann Nucl Med 27, 886–891 (2013). https://doi.org/10.1007/s12149-013-0763-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-013-0763-z

Keywords

Search

Navigation